Single Photon Emission Computed Tomography/Computed Tomography (SPECT/CT) Prospective Double-Scanning Study
← catalyst calendarNCT07725237 · readout ≤ 193 d
Sponsored by GE Healthcare (industry) · GEHC — their whole pipeline →. With Rambam Health Care Campus.
Phase
—
Status
Recruiting
Study type
Observational
Enrollment
30estimated
Sites
1
Country
Israel
Every value on this page is a field the sponsor filed with ClinicalTrials.gov, reproduced. Dates are their own estimates, revised as a study runs, unless the registry marks them actual. sources →
Source: ClinicalTrials.gov, retrieved 2026-08-19
Dates
each axis at the precision it was filed, with the registry's own basis| Date | Filed | Basis | What it is |
|---|---|---|---|
| Start | 2026-07-20 | actual | When the study began enrolling |
| Primary completion | Feb 2027 | estimated | The date the last participant is measured for the primary outcome — the readout window |
| Study completion | Feb 2027 | estimated | The whole study's end, after follow-up |
| First posted | 2026-07-24 | actual | When this record first appeared on the registry |
| Results posted | — | When the sponsor posted results to the registry | |
| Record updated | 2026-08-19 | actual | The sponsor's own last edit to this record — every projection above is as current as this date |
What it studies
Condition
- SPECT-CT
Intervention
- Device: StarGuide GX SPECT/CT Scan
Primary outcome
what the primary-completion date above is the date OFNumber of StarGuide GX Data Files Collected
measured Through study completion, an average of 1 year
Permalink · GEHC's whole pipeline · Catalyst calendar · Every registered study · What changed